Core Scientific Inc (CORZ) can make a big difference with a little luck

With 4.86 million shares changed hands, the volume of the stock remained lighter than its average volume of 10.74 million shares. The 52-week range on CORZ shows that it touched its highest point at $18.63 and its lowest point at $2.61 during that stretch. It currently has a 1-year price target of $20.79. Beta for the stock currently stands at 6.82.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CORZ was down-trending over the past week, with a drop of -1.96%, but this was down by -19.87% over a month. Three-month performance dropped to -22.15% while six-month performance rose 19.13%. The stock gained 232.04% in the past year, while it has lost -14.45% so far this year. A look at the trailing 12-month EPS for CORZ yields -5.45 with Next year EPS estimates of 0.12. For the next quarter, that number is -0.09. This implies an EPS growth rate of -513.17% for this year and 103.09% for next year.

Float and Shares Shorts:

At present, 279.82 million CORZ shares are outstanding with a float of 243.92 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CORZ since 6 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.48845 being high and -$4.4745 being low. For CORZ, this leads to a yearly average estimate of -$3.98562. Based on analyst estimates, the high estimate for the next quarter is $0.17 and the low estimate is $0.17. The average estimate for the next quarter is thus $0.17.